Türkçe Özet:Nazal epitelin yüksek geçirgenliği, geniş absorpsiyon alanının varlığı, kan akımının hızlı olması gibi avantajları ile nazal yol; sistemik etki için pek çok ilacın alternatif veriliş yolu haline gelmiştir. İlacın nazal mukozadan geçişinde pek çok faktör rol oynamaktadır. Bu faktörler arasında başta etkin maddenin molekül ağırlığı gelmektedir. Düşük molekül ağırlığına sahip nazal uygulanan ilaçlar eczane raflarında yerini alırken, son yıllarda yüksek molekül ağırlığına sahip ilaçların (peptit ve protein) da nazal verilişi yaygın olarak araştırılmaktadır. Yapılan çalışmalar nazal yolla kullanılan penetrasyon arttırıcı maddelerin, ilaçların nazal mukozadan geçişinde son derece etkin olduğunu göstermiştir. Diğer bir yaklaşım da formülasyonlarda yeni ilaç taşıyıcı sistemlerin (emülsiyon, mikroemülsiyon, lipozom, insert, mikro- ve nanopartiküller) kullanılmasıdır. Bu derlemede, nazal yolun özellikleri, mukus sekresyonu ve mukosiliyer klerens, nazal mukozadan ilacın absorpsiyonunu etkileyen faktörler, nazal mukozadan geçiş ve geçişin arttırılması ve yeni nazal dozaj şekilleri ele alınmıştır.
AbstractNasal Route for Systemic Effect Nasal route has become an alternative route of delivery for a large number of drugs to produce systemic effect as it possesses advantageous such as high permeability, wide area of absorption, rapid blood flow. A numerous parameters play important role in drug transport through the nasal mucosa. Among of these factors, molecular weight of drugs is the most important one. While the low molecular weight drugs in nasal forms with systemic effect are currently taking place in the shelves of pharmacy stores, nasal administration of high molecular weight drugs (e.g. peptide and proteins) have also been widely investigated. The studies conducted on the subject indicated that the penetration enhancers for nasal delivery are highly effective in the transport of drugs through nasal mucosal membrane. Another approach is to use the novel drug carriers (emulsions, microemulsions, liposomes, inserts, micro- and nanoparticulates) in formulations for nasal delivery. In this article, the properties of nasal route, mucus secretion, mucociliary clearance, parameters affecting nasal drug absorption, transport mechanisms across nasal mucosa, enhancement of drug transport, and novel nasal dosage forms were reviewed.
Primary Language | Turkish |
---|---|
Journal Section | Articles |
Authors | |
Publication Date | September 1, 2009 |
Submission Date | June 13, 2014 |
Published in Issue | Year 2009 Volume: 2 Issue: 3 |
MEU Journal of Health Sciences Assoc was began to the publishing process in 2008 under the supervision of Assoc. Prof. Gönül Aslan, Editor-in-Chief, and affiliated to Mersin University Institute of Health Sciences. In March 2015, Prof. Dr. Caferi Tayyar Şaşmaz undertook the Editor-in Chief position and since then he has been in charge.
Publishing in three issues per year (April - August - December), it is a multisectoral refereed scientific journal. In addition to research articles, scientific articles such as reviews, case reports and letters to the editor are published in the journal. Our journal, which has been published via e-mail since its inception, has been published both online and in print. Following the Participation Agreement signed with TÜBİTAK-ULAKBİM Dergi Park in April 2015, it has started to accept and evaluate online publications.
Mersin University Journal of Health Sciences have been indexed by Turkey Citation Index since November 16, 2011.
Mersin University Journal of Health Sciences have been indexed by ULAKBIM Medical Database from the first issue of 2016.
Mersin University Journal of Health Sciences have been indexed by DOAJ since October 02, 2019.
Article Publishing Charge Policy: Our journal has adopted an open access policy and there is no fee for article application, evaluation, and publication in our journal. All the articles published in our journal can be accessed from the Archive free of charge.
This work is licensed with Attribution-NonCommercial 4.0 International.